Free tool
FAERS Monitor: Zyprexa
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020592 or its brand name (Zyprexa, Olanzapine). Reports on generic versions are filed under their own applications.
Reports
108,111
Serious
93,316
86% of reports
Hospitalization
47,645
Death reported
13,364
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective7,525
- weight increased6,834
- off label use6,066
- diabetes mellitus5,394
- toxicity to various agents4,383
- drug interaction4,289
- nausea4,114
- somnolence4,007
- fatigue3,663
- anxiety3,460
- overdose3,449
- vomiting3,326
- suicide attempt3,245
- condition aggravated3,021
- confusional state2,912
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 2,191 |
| 2005 | 3,175 |
| 2006 | 3,603 |
| 2007 | 3,532 |
| 2008 | 1,855 |
| 2009 | 3,604 |
| 2010 | 3,238 |
| 2011 | 3,251 |
| 2012 | 2,970 |
| 2013 | 2,560 |
| 2014 | 2,945 |
| 2015 | 7,854 |
| 2016 | 3,892 |
| 2017 | 4,788 |
| 2018 | 6,068 |
| 2019 | 6,665 |
| 2020 | 6,148 |
| 2021 | 6,265 |
| 2022 | 7,084 |
| 2023 | 6,875 |
| 2024 | 7,033 |
| 2025 | 7,207 |
| 2026 | 5,307 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,946,048 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| diabetes mellitusSignal | 5,394 | 14.7 | 14.3 | 64,404 |
| suicide attemptSignal | 3,245 | 10.9 | 10.6 | 27,821 |
| weight increasedSignal | 6,834 | 6.1 | 6.0 | 28,500 |
| drug interactionSignal | 4,289 | 5.4 | 5.2 | 14,981 |
| toxicity to various agentsSignal | 4,383 | 5.2 | 5.0 | 14,449 |
| somnolenceSignal | 4,007 | 3.9 | 3.8 | 8,658 |
| confusional stateSignal | 2,912 | 3.6 | 3.4 | 5,281 |
| overdoseSignal | 3,449 | 3.1 | 3.0 | 5,014 |
| anxietySignal | 3,460 | 2.4 | 2.3 | 2,777 |
| condition aggravated | 3,021 | 1.9 | 1.9 | 1,387 |
| vomiting | 3,326 | 1.4 | 1.3 | 351 |
| off label use | 6,066 | 1.4 | 1.3 | 570 |
| drug ineffective | 7,525 | 1.1 | 1.1 | 89 |
| nausea | 4,114 | 1.0 | 1.0 | 1 |
| fatigue | 3,663 | 0.9 | 0.9 | 30 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.